Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
24.55
+0.02 (0.08%)
At close: Mar 27, 2024, 4:00 PM
25.77
+1.22 (4.97%)
After-hours: Mar 27, 2024, 7:49 PM EDT

Bicycle Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Revenue
26.9814.4611.710.3913.87.142.06
Revenue Growth (YoY)
86.52%23.65%12.58%-24.72%93.40%246.41%-
Gross Profit
26.9814.4611.710.3913.87.142.06
Selling, General & Admin
60.4349.5132.4429.214.568.126.41
Research & Development
156.581.6144.8833.1525.5420.7611.87
Operating Expenses
216.92131.1277.3262.3540.128.8818.27
Operating Income
-189.95-116.65-65.62-51.96-26.3-21.75-16.21
Interest Expense / Income
3.263.342.980.46000
Other Expense / Income
-14-5.76-0.12-0.684.560.50.07
Pretax Income
-179.21-114.24-68.48-51.73-30.86-22.24-16.28
Income Tax
1.46-1.52-1.66-0.72-0.25-0.4-0.02
Net Income
-180.66-112.72-66.82-51.01-30.61-21.85-16.26
Shares Outstanding (Basic)
363025191100
Shares Outstanding (Diluted)
363025191100
Shares Change
20.00%18.35%30.90%73.34%2416.82%31.74%-
EPS (Basic)
-5.08-3.80-2.67-2.66-2.77-49.78-48.81
EPS (Diluted)
-5.08-3.80-2.67-2.66-2.77-49.78-48.81
Free Cash Flow
-63.56-105.1-16.82-18.99-30.17-27.26-2.53
Free Cash Flow Per Share
-1.79-3.54-0.67-0.99-2.73-62.12-7.59
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-704.13%-806.56%-560.98%-500.10%-190.56%-304.74%-787.04%
Profit Margin
-669.72%-779.35%-571.25%-490.95%-221.78%-306.14%-789.27%
Free Cash Flow Margin
-235.61%-726.67%-143.83%-182.76%-218.59%-382.06%-122.72%
EBITDA
-169.4-107.21-64.09-50-29.9-21.53-15.95
EBITDA Margin
-627.96%-741.26%-547.91%-481.23%-216.67%-301.71%-774.27%
Depreciation & Amortization
6.553.691.411.280.960.710.33
EBIT
-175.94-110.9-65.5-51.28-30.86-22.24-16.28
EBIT Margin
-652.22%-766.76%-559.96%-493.52%-223.62%-311.69%-790.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).